Skip to main content
TipRanks
Go Ultimate75% OFF

Love Pharma Inc (JOLT.X) Stock Statistics & Valuation Metrics

13 Followers

Total Valuation

Love Pharma Inc has a market cap or net worth of CAD 190.93K. The enterprise value is CAD 861.03K.

Market Cap
CAD 190.93K
Enterprise Value
CAD 861.03K

Share Statistics

Love Pharma Inc has 12,728,754 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
12,728,754
Owned by Insiders
18.41%
Owned by Institutions
―

Financial Efficiency

Love Pharma Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
―
Employee Count
0
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Love Pharma Inc had revenue of ― and earned 43.78K in profits. Earnings per share was ―.

Revenue
―
Gross Profit
0
Operating Income
-63.71K
Pretax Income
―
Net Income
43.78K
EBITDA
-63.71K
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
-0.77
52-Week Price Change
-81.25%
50-Day Moving Average
0.02
200-Day Moving Average
0.06
Relative Strength Index (RSI)
22.46
Average Volume (3m)
79.93K

Important Dates

Love Pharma Inc upcoming earnings date is May 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 28, 2026
Next Earnings Date
May 03, 2027
Ex-Dividend Date
―

Balance Sheet

Love Pharma Inc has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
CAD 0.00
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Love Pharma Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
83.38%